Intranasal Immunization with a Recombinant Adenovirus Encoding Multi-Stage Antigens of Preferentially Elicited CD8 T Cell Immunity and Conferred a Superior Protection in the Lungs of Mice Than Bacillus Calmette-Guerin

Overview

Journal Vaccines (Basel)

Date 2024 Sep 28

PMID 39340053

Authors

Limei Wang

Jian Kang

Hong Jiang

Affiliations

Soon will be listed here.

Abstract

The development of a tuberculosis (TB) vaccine is imperative. Employing multi-stage (Mtb) antigens as targeted antigens represents a critical strategy in establishing an effective novel TB vaccine. In this investigation, we evaluated the immunogenicity and protective efficacy of a recombinant adenovirus vaccine expressing two fusion proteins, Ag85B-ESAT6 (AE) and Rv2031c-Rv2626c (R2), derived from multi-stage antigens of Mtb via intranasal administration in mice. Intranasal delivery of Ad-AE-R2 induced both long-lasting mucosal and systemic immunities, with a preferential elicitation of CD8 T cell immunity demonstrated by the accumulation and retention of CD8 T cells in BALF, lung, and spleen, as well as the generation of CD8 TRM cells in BALF and lung tissues. Compared to subcutaneous immunization with Bacillus Calmette-Guerin (BCG), Ad-AE-R2 provided superior protection against high-dose intratracheal BCG challenge, specifically within the lungs of mice. Our findings support the notion that empowering T cells within the respiratory mucosa is crucial for TB vaccine development while highlighting targeting CD8 T cell immunity as an effective strategy for optimizing TB vaccines and emphasizing that eliciting systemic memory immunity is also vital for the successful development of a TB mucosal vaccine. Furthermore, our results demonstrate that the BCG challenge serves as a convenient and efficient method to evaluate candidate vaccine efficacy.

References

Lin P, Flynn J . CD8 T cells and Mycobacterium tuberculosis infection. Semin Immunopathol. 2015; 37(3):239-49. PMC: 4439333. DOI: 10.1007/s00281-015-0490-8. View

Dong C . Cytokine Regulation and Function in T Cells. Annu Rev Immunol. 2021; 39:51-76. DOI: 10.1146/annurev-immunol-061020-053702. View

Santosuosso M, Zhang X, McCormick S, Wang J, Hitt M, Xing Z . Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J Immunol. 2005; 174(12):7986-94. DOI: 10.4049/jimmunol.174.12.7986. View

Li M, Wang Y, Sun Y, Cui H, Zhu S, Qiu H . Mucosal vaccines: Strategies and challenges. Immunol Lett. 2019; 217:116-125. DOI: 10.1016/j.imlet.2019.10.013. View

Beverley P, Sridhar S, Lalvani A, Tchilian E . Harnessing local and systemic immunity for vaccines against tuberculosis. Mucosal Immunol. 2013; 7(1):20-6. DOI: 10.1038/mi.2013.99. View

Gebre M, Brito L, Tostanoski L, Edwards D, Carfi A, Barouch D . Novel approaches for vaccine development. Cell. 2021; 184(6):1589-1603. PMC: 8049514. DOI: 10.1016/j.cell.2021.02.030. View

Darrah P, Zeppa J, Wang C, Irvine E, Bucsan A, Rodgers M . Airway T cells are a correlate of i.v. Bacille Calmette-Guerin-mediated protection against tuberculosis in rhesus macaques. Cell Host Microbe. 2023; 31(6):962-977.e8. PMC: 10355173. DOI: 10.1016/j.chom.2023.05.006. View

Chen T, Blanc C, Liu Y, Ishida E, Singer S, Xu J . Capsular glycan recognition provides antibody-mediated immunity against tuberculosis. J Clin Invest. 2020; 130(4):1808-1822. PMC: 7108924. DOI: 10.1172/JCI128459. View

Yousefi Avarvand A, Khademi F, Tafaghodi M, Ahmadipour Z, Moradi B, Meshkat Z . The roles of latency-associated antigens in tuberculosis vaccines. Indian J Tuberc. 2019; 66(4):487-491. DOI: 10.1016/j.ijtb.2019.04.012. View

10.

Roupie V, Romano M, Zhang L, Korf H, Lin M, Franken K . Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice. Infect Immun. 2006; 75(2):941-9. PMC: 1828490. DOI: 10.1128/IAI.01137-06. View

11.

Lin M, Ottenhoff T . Host-pathogen interactions in latent Mycobacterium tuberculosis infection: identification of new targets for tuberculosis intervention. Endocr Metab Immune Disord Drug Targets. 2008; 8(1):15-29. DOI: 10.2174/187153008783928398. View

12.

Biffar L, Blunt L, Atkins W, Anderson P, Holder T, Xing Z . Evaluating the sensitivity of the bovine BCG challenge model using a prime boost Ad85A vaccine regimen. Vaccine. 2019; 38(5):1241-1248. DOI: 10.1016/j.vaccine.2019.11.005. View

13.

Greenbaum E, Furst A, Kiderman A, Stewart B, Levy R, Schlesinger M . Mucosal [SIgA] and serum [IgG] immunologic responses in the community after a single intra-nasal immunization with a new inactivated trivalent influenza vaccine. Vaccine. 2002; 20(7-8):1232-9. DOI: 10.1016/s0264-410x(01)00396-6. View

14.

Cheuk S, Schlums H, Gallais Serezal I, Martini E, Chiang S, Marquardt N . CD49a Expression Defines Tissue-Resident CD8 T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017; 46(2):287-300. PMC: 5337619. DOI: 10.1016/j.immuni.2017.01.009. View

15.

Qu M, Zhou X, Li H . BCG vaccination strategies against tuberculosis: updates and perspectives. Hum Vaccin Immunother. 2021; 17(12):5284-5295. PMC: 8903987. DOI: 10.1080/21645515.2021.2007711. View

16.

Mueller S, Mackay L . Tissue-resident memory T cells: local specialists in immune defence. Nat Rev Immunol. 2015; 16(2):79-89. DOI: 10.1038/nri.2015.3. View

17.

Gregory A, Schaik E, Russell-Lodrigue K, Fratzke A, Samuel J . Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates. Infect Immun. 2019; 87(12). PMC: 6867829. DOI: 10.1128/IAI.00178-19. View

18.

Fatima S, Kumari A, Das G, Dwivedi V . Tuberculosis vaccine: A journey from BCG to present. Life Sci. 2020; 252:117594. DOI: 10.1016/j.lfs.2020.117594. View

19.

Gonzalez-Juarrero M, Bosco-Lauth A, Podell B, Soffler C, Brooks E, Izzo A . Experimental aerosol Mycobacterium bovis model of infection in goats. Tuberculosis (Edinb). 2013; 93(5):558-64. DOI: 10.1016/j.tube.2013.05.006. View

20.

Horvath C, Shaler C, Jeyanathan M, Zganiacz A, Xing Z . Mechanisms of delayed anti-tuberculosis protection in the lung of parenteral BCG-vaccinated hosts: a critical role of airway luminal T cells. Mucosal Immunol. 2012; 5(4):420-31. DOI: 10.1038/mi.2012.19. View